Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
signifor 0.6 mg/1 ml solution injectable
recordati ag - pasireotidum - solution injectable - pasireotidum 0.6 mg ut pasireotidi diaspartas, mannitolum, acidum tartaricum, natrii hydroxidum q.s. ad ph, aqua ad iniectabile ad solutionem pro 1 ml. - behandlung von la maladie de cushing - synthetika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
signifor 0.9 mg/1 ml solution injectable
recordati ag - pasireotidum - solution injectable - pasireotidum 0.9 mg ut pasireotidi diaspartas, mannitolum, acidum tartaricum, natrii hydroxidum q.s. ad ph, aqua ad iniectabile ad solutionem pro 1 ml. - behandlung von la maladie de cushing - synthetika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
reagila 1.5 mg gélules
recordati ag - cariprazinum - gélules - cariprazinum 1.5 mg ut cariprazini hydrochloridum, amylum pregelificatum, magnesii stearas, kapselhülle: gelatina, e 171, drucktinte: e 172 (nigrum), lacca, aqua purificata, propylenglycolum, kalii hydroxidum, pro capsula. - neuroleptiques - synthetika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
reagila 3 mg gélules
recordati ag - cariprazinum - gélules - cariprazinum 3 mg ut cariprazini hydrochloridum, amylum pregelificatum, magnesii stearas, kapselhülle: gelatina, e 129 0.3 µg, e 133, e 171, e 172 (flavum), drucktinte: e 172 (nigrum), lacca, aqua purificata, propylenglycolum, kalii hydroxidum, pro capsula. - neuroleptiques - synthetika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
reagila 4.5 mg gélules
recordati ag - cariprazinum - gélules - cariprazinum 4.5 mg ut cariprazini hydrochloridum, amylum pregelificatum, magnesii stearas, kapselhülle: gelatina, e 129 0.8 µg, e 133, e 171, e 172 (flavum), drucktinte: lacca, e 171, propylenglycolum, simeticonum, pro capsula. - neuroleptiques - synthetika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
reagila 6 mg gélules
recordati ag - cariprazinum - gélules - cariprazinum 6 mg ut cariprazini hydrochloridum, amylum pregelificatum, magnesii stearas, kapselhülle: gelatina, e 129 9.6 µg, e 133, e 171, drucktinte: e 172 (nigrum), lacca, aqua purificata, propylenglycolum, kalii hydroxidum, pro capsula. - neuroleptiques - synthetika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
isturisa 1 mg comprimés pelliculés
recordati ag - osilodrostatum - comprimés pelliculés - osilodrostatum 1 mg ut osilodrostati phosphas, excipiens pro compresso obducto. - zur behandlung von morbus cushing und anderen ursachen eines endogenen hypercortisolismus (z.b. nebennierenrinden adenom, bilaterale nnr-hyperplasie, ektope acth-sekretion) - synthetika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
isturisa 5 mg comprimés pelliculés
recordati ag - osilodrostatum - comprimés pelliculés - osilodrostatum 5 mg ut osilodrostati phosphas, excipiens pro compresso obducto. - zur behandlung von morbus cushing und anderen ursachen eines endogenen hypercortisolismus (z.b. nebennierenrinden adenom, bilaterale nnr-hyperplasie, ektope acth-sekretion) - synthetika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
isturisa 10 mg comprimés pelliculés
recordati ag - osilodrostatum - comprimés pelliculés - osilodrostatum 10 mg ut osilodrostati phosphas, excipiens pro compresso obducto. - zur behandlung von morbus cushing und anderen ursachen eines endogenen hypercortisolismus (z.b. nebennierenrinden adenom, bilaterale nnr-hyperplasie, ektope acth-sekretion) - synthetika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
cystadrops 3.8 mg/ml collyre
recordati ag - mercaptaminum - collyre - mercaptaminum 3.8 mg ut mercaptamini hydrochloridum, carmellosum natricum, benzalkonii chloridum 0.1 mg, dinatrii edetas, acidum citricum monohydricum, natrii hydroxidum, acidum hydrochloridum, natrii hydroxidum ad ph, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - cystinablagerungen in der hornhaut - synthetika